Skip to main content

Published locations for ICYMI: Durvalumab boosts overall survival in stage III NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ICYMI: Durvalumab boosts overall survival in stage III NSCLC

User login

  • Reset your password
  • /content/icymi-durvalumab-boosts-overall-survival-stage-iii-nsclc
  • /oncologypractice/article/190821/lung-cancer/icymi-durvalumab-boosts-overall-survival-stage-iii-nsclc
  • /hematology-oncology/article/190821/lung-cancer/icymi-durvalumab-boosts-overall-survival-stage-iii
  • /chestphysician/article/190821/lung-cancer/icymi-durvalumab-boosts-overall-survival-stage-iii-nsclc